Replies to post #11899 on Momenta Pharmaceuticals, Inc. (MNTA)

[linhdtu]

Indeed that is a quibble. Nothing stopped NVS from inking a deal with mnta regarding FOB. Nevertheless it is their decision and as a retailer I don't know why.
But I did know this. Lilly was a partner with Amylin for yrs and it did not want any part with Bydureon (a once weekly version of Byetta) and sold it back to Amy for 1B$ or so.
AF made the same comment. If Lilly which is a close partner didn't want Bydureon, it must be crap.
Well, that crap was bought out by BMY and Azn for 6-7B$ (can't remember the exact number anymore) about a yr later.